ENTA
Enanta Pharmaceuticals Inc
Price:  
7.00 
USD
Volume:  
1,016,543.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA WACC - Weighted Average Cost of Capital

The WACC of Enanta Pharmaceuticals Inc (ENTA) is 8.5%.

The Cost of Equity of Enanta Pharmaceuticals Inc (ENTA) is 8.55%.
The Cost of Debt of Enanta Pharmaceuticals Inc (ENTA) is 5.00%.

Range Selected
Cost of equity 7.30% - 9.80% 8.55%
Tax rate 1.90% - 2.50% 2.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.3% - 9.8% 8.5%
WACC

ENTA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.74 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.80%
Tax rate 1.90% 2.50%
Debt/Equity ratio 0.01 0.01
Cost of debt 5.00% 5.00%
After-tax WACC 7.3% 9.8%
Selected WACC 8.5%